Page 1 of Clinical Trials for Drug Ascorbic acid, 270 Total Matches
- 1Active, not recruitingLast Updated: November 20, 2009Condition(s): Contrast Induced Nephropathy
- 2RecruitingLast Updated: November 22, 2011Condition(s): Type 2 Diabetes Mellitus
- 3WithdrawnLast Updated: December 4, 2006Condition(s): Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
- 4Active, not recruitingLast Updated: October 25, 2011Condition(s): Myelodysplastic Syndromes and Leukemia, Myeloid, Acute
- 5Not yet recruitingLast Updated: December 29, 2011Condition(s): Drug Safety
- 6WithdrawnLast Updated: February 28, 2011Condition(s): HIV Infections
- 7TerminatedLast Updated: June 4, 2010Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 8Not yet recruitingLast Updated: May 1, 2012Condition(s): Pancreatic Neoplasms; Pancreatic Cancer
- 9CompletedLast Updated: January 6, 2012Condition(s): Gallbladder Inflammation
- 10Recruiting
- 11TerminatedLast Updated: April 18, 2011Condition(s): Acute Myelogenous Leukemia
- 12RecruitingLast Updated: April 27, 2012Condition(s): Focus of the Study: DNA Damage Due to Medical Diagnostic X-ray
- 13Not yet recruitingLast Updated: May 14, 2009Condition(s): Atopic Dermatitis
- 14CompletedLast Updated: May 16, 2011Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
- 15CompletedLast Updated: May 10, 2012Condition(s): Atrial Fibrillation; Atrial Flutter
- 16CompletedLast Updated: March 12, 2012Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 17CompletedLast Updated: February 27, 2008Condition(s): Hypoxic Ischemic Encephalopathy; Perinatal Asphyxia
- 18CompletedLast Updated: June 30, 2011Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 19WithdrawnLast Updated: July 6, 2006Condition(s): Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
- 20CompletedLast Updated: February 6, 2009Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Ascorbic+acid
